Stratified medicine: drugs meet genetics

Ian P. Hall

Source: Eur Respir Rev 2013; 22: 53-57
Journal Issue: March 2013 - 22 (127)

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Ian P. Hall. Stratified medicine: drugs meet genetics. Eur Respir Rev 2013; 22: 53-57

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Surfactant protein B polymorphisms, pulmonary function and COPD in 10,231 individuals
Source: Eur Respir J 2011; 37: 791-799
Year: 2011



Gender differences in the natural history of pulmonary diseases
Source: ISSN=1025-448x, ISBN=1-904097-28-6, page=74
Year: 2003

Prognosis: what is the contribution of inflammation to the decline in lung function in airway disease?
Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease
Year: 2007


Recommendations for epidemiological studies on COPD
Source: Eur Respir J 2011; 38: 1261-1277
Year: 2011



Genetics of fibrosing lung diseases
Source: Eur Respir J 2005; 25: 915-927
Year: 2005



Novel insights into the genetics of smoking behaviour, lung function and chronic obstructive pulmonary disease in UK Biobank
Source: International Congress 2015 – Asthma: emerging risk factors and current management of the patient
Year: 2015



Determinants of success
Source: Eur Respir J 2011; 38: 1215-1218
Year: 2011



Clinical characteristics of postoperative pulmonary infection in lung cancer patients with obstructive pulmonary disease: the trend of microorganisms in bronchial colonization
Source: Annual Congress 2006 - Contemporary issues in thoracic surgical oncology
Year: 2006


The link between inflammation and lung cancer: lessons from chronic obstructive pulmonary disease
Source: International Congress 2018 – Scientific Year in Review
Year: 2018


COPD prevalence is increased in lung cancer, independent of age, sex and smoking history
Source: Eur Respir J 2009; 33: 380-386
Year: 2009



Clinical highlights from the 2011 ERS Congress in Amsterdam
Source: Eur Respir J 2012; 39: 1501-1510
Year: 2012



Pathology of chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=159
Year: 2006

Distinct clinical phenotypes of airways disease defined by cluster analysis
Source: Eur Respir J 2009; 34: 812-818
Year: 2009



Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013

Common airway variants and chronic obstructive pulmonary disease
Source: International Congress 2015 – New observations in respiratory epidemiology
Year: 2015

Interstital lung diseases: update 2005
Source: Annual Congress 2005 - Clinical year in review
Year: 2005

T-cell pathways in lung tissue of patients with advanced COPD and IPF requiring lung transplantation
Source: International Congress 2016 – Mechanisms of disease
Year: 2016


Relationship between lung cancer and chronic obstructive pulmonary disease
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014


The impact of chronic obstructive pulmonary disease on survival of the patients with small-cell lung cancer
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015